LOAMU
VIVO

Lombard Odier Asset Management (USA)’s Meridian Bioscience Inc VIVO Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35,000
Closed -$1.16M – 431
2022
Q4 		$1.16M Hold
35,000
– – 0.03% 198
2022
Q3 		$1.1M Buy
+35,000
New +$1.13M 0.03% 208

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s VIVO Position: Q1 2023 in Review

Lombard Odier Asset Management (USA) sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 35,000 shares — an estimated $1.16M sold.

Lombard Odier Asset Management (USA) first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $1.16M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Lombard Odier Asset Management (USA) reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 35,000 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.16M.
  • Lombard Odier Asset Management (USA) first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
  • Lombard Odier Asset Management (USA)'s Meridian Bioscience Inc position peaked at $1.16M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2023, filed 15 May 2023.